Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.

Liu, Yi; Liu, Haijuan; Li, Mei; Zhou, Peiran; Xing, Xiaoping; Xia, Weibo; Zhang, Zhenlin; Liao, Eryuan; Chen, Decai; Liu, Jian; Tao, Tianzun; Wu, Wen; Xu, Ling

Liu, Yi; Liu, Haijuan; Li, Mei; Zhou, Peiran; Xing, Xiaoping; Xia, Weibo; Zhang, Zhenlin; Liao, Eryuan; Chen, Decai; Liu, Jian; Tao, Tianzun; Wu, Wen; Xu, Ling.

Afiliação

Liu Y; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Liu H; Department of Endocrinology, People's Hospital of Liaocheng, Liaocheng, Shandong 252002, China.
Li M; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China. Email: limeilzh@sina.com.
Zhou P; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Xing X; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Xia W; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhang Z; Metabolic Bone Disease and Genetics Research Unit, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated with Shanghai Jiao Tong University, Shanghai 200233, China.
Liao E; Institute of Endocrinology and Metabolism, Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Chen D; Department of Endocrinology, Osteoporosis Education Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Liu J; Department of Orthopedics, Xijing Hospital, Fourth Liberation Army University, Xi'an, Shannxi 710032, China.
Tao T; Department of Orthopedics, Harbin Medical University Affiliated Second Hospital, Harbin, Heilongjiang 150081, China.
Wu W; Department of Endocrinology, Guangdong General Hospital, Guangzhou, Guangdong 510080, China.
Xu L; Department of Obstetrics and Gynecology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

Chin Med J (Engl) ; 127(4): 662-8, 2014.

Article em En | MEDLINE | ID: mdl-24534219

Assuntos

Alendronato/uso terapêutico; Conservadores da Densidade Óssea/uso terapêutico; Geraniltranstransferase/genética; Osteoporose Pós-Menopausa/tratamento farmacológico; Polimorfismo Genético; Povo Asiático; Feminino; Humanos; Pessoa de Meia-Idade; Osteoporose Pós-Menopausa/genética

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Osteoporose Pós-Menopausa / Alendronato / Geraniltranstransferase / Conservadores da Densidade Óssea Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: China País de publicação: China

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links